- The U.S. Defense Health Agency (DHA) has selected Parsons Corp (NYSE:PSN) to provide health-related research and development and additional activities of interest for the Department of Defense and the Military Healthcare System.
- Omnibus IV is a five-year multiple-award IDIQ contract with one five-year option period and a $10 billion ceiling value.
- The Omnibus IV Military Medical Research and Development contract is a continuation of successful past government investments focused on discovering and integrating medical innovations and material solutions.
- Price Action: PSN shares are trading lower by 3.65% at $36.48 on the last check Thursday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Parsons Assists US Defense Health Agency On Omnibus IV Contract
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks